On October 19, 2020, Hang Seng Indexes Co., Ltd. launched four new indexes: Hang Seng Large-Mid Cap (Investable) Index, Hang Seng Small Cap (Investable) Index, Hang Seng Shanghai-Shenzhen-Hong Kong NextGen Communications Index and Hang Seng Shanghai-Shenzhen-Hong Kong E-Commerce Index. China Medical System Holdings Limited (“CMS”) has been included in the Hang Seng Large-Mid Cap (Investable) Index, which measures the performance of investable LargeCap and MidCap stocks
in the Hong Kong market with 267 constituents.
CMS is a well-established, innovation-driven specialty pharma with a focus on sales and marketing in
China. The inclusion in the Hang Seng Large-Mid Cap (Investable) Index will further enhance capital market’s understanding of the company’s long-term investment value. The Group has been already included in the Morgan Stanley Capital International (MSCI) China Index as well as the Hang Seng Stock Connect Biotech 50 Index (HSSCB50), and is the object of transaction in both Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect.